{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:56:23Z","timestamp":1769604983355,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,7,17]],"date-time":"2010-07-17T00:00:00Z","timestamp":1279324800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1007\/s11255-010-9805-9","type":"journal-article","created":{"date-parts":[[2010,7,16]],"date-time":"2010-07-16T04:24:06Z","timestamp":1279254246000},"page":"835-840","source":"Crossref","is-referenced-by-count":17,"title":["Risk factors for high erythropoiesis stimulating agent resistance index in pre-dialysis chronic kidney disease patients, stages 4 and 5"],"prefix":"10.1007","volume":"43","author":[{"given":"Ana","family":"de Lurdes Agostinho Cabrita","sequence":"first","affiliation":[]},{"given":"Ana","family":"Pinho","sequence":"additional","affiliation":[]},{"given":"Anabela","family":"Malho","sequence":"additional","affiliation":[]},{"given":"Elsa","family":"Morgado","sequence":"additional","affiliation":[]},{"given":"Mar\u00edlia","family":"Fa\u00edsca","sequence":"additional","affiliation":[]},{"given":"Herm\u00ednio","family":"Carrasqueira","sequence":"additional","affiliation":[]},{"given":"Ana Paula","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Pedro Le\u00e3o","family":"Neves","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2010,7,17]]},"reference":[{"key":"9805_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ki.1985.109","volume":"28","author":"JW Eschbach","year":"1985","unstructured":"Eschbach JW, Adamson JW (1985) Anemia of end-stage renal disease. Kidney Int 28:1\u20135","journal-title":"Kidney Int"},{"key":"9805_CR2","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(86)92192-6","volume":"2","author":"CG Winearls","year":"1986","unstructured":"Winearls CG, Oliver DO, Pippard MJ et al (1986) Effect of human erythropoietin derived from recombinant DNA on the anemia of patients maintained by chronic hemodialysis. Lancet 2:1175\u20131177","journal-title":"Lancet"},{"key":"9805_CR3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM198701083160203","volume":"316","author":"JW Eschbach","year":"1987","unstructured":"Eschbach JW, Egrie JC, Downing MR et al (1987) Correction of the anemia of end-stage renal disease with recombinant human erythropoietin: results of phase I and II clinical trial. N Engl J Med 316:73\u201378","journal-title":"N Engl J Med"},{"key":"9805_CR4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0272-6386(95)90105-1","volume":"25","author":"RL Wingard","year":"1995","unstructured":"Wingard RL, Parker RA, Ismail L et al (1995) Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin. Am J Kidney Dis 25:433\u2013439","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 8","key":"9805_CR5","first-page":"viii7","volume":"18","author":"DS Silverberg","year":"2003","unstructured":"Silverberg DS, Wexler D, Blum M et al (2003) The cardio-renal anaemia syndrome: does it exist? Nephrol Dial Transplant 18(Suppl 8):viii7\u2013viii12","journal-title":"Nephrol Dial Transplant"},{"key":"9805_CR6","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1681\/ASN.V12112465","volume":"12","author":"AJ Collins","year":"2001","unstructured":"Collins AJ, Li S, Peter W et al (2001) Death, hospitalization and economic associations among incident haemodialysis patients with hematocrit values of 36 to 39%. J Am Soc Nephrol 12:2465\u20132473","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 11","key":"9805_CR7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/ndt\/17.suppl_11.32","volume":"17","author":"RN Foley","year":"2002","unstructured":"Foley RN (2002) Anaemia: cardiovascular adaptations and maladaptative responses in chronic kidney disease. Nephrol Dial Transplant 17(Suppl 11):32\u201334","journal-title":"Nephrol Dial Transplant"},{"key":"9805_CR8","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ahj.2005.03.055","volume":"151","author":"BC Astor","year":"2006","unstructured":"Astor BC, Coresh J, Heiss G et al (2006) Kidney function and anemia as risk factors for coronary heart disease and mortality: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J 151:492\u2013500","journal-title":"Am Heart J"},{"key":"9805_CR9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1681\/ASN.2005050553","volume":"17","author":"SR Leeder","year":"2006","unstructured":"Leeder SR, Mitchell P, Liew G et al (2006) Low hemoglobin, chronic kidney disease, and risk for coronary heart disease-related death: the Blue Mountains Eye study. J Am Soc Nephrol 17:279\u2013288","journal-title":"J Am Soc Nephrol"},{"key":"9805_CR10","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/snep.2001.20939","volume":"21","author":"EM Tong","year":"2001","unstructured":"Tong EM, Nisseson AR (2001) Erythropoietin and anemia. Semin Nephrol 21:190\u2013203","journal-title":"Semin Nephrol"},{"issue":"suppl 2","key":"9805_CR11","first-page":"ii32","volume":"19","author":"Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Section IV","year":"2004","unstructured":"Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Section IV (2004) Failure to respond to treatment. Nephrol Dial Transplant 19(suppl 2):ii32\u2013ii36","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 11","key":"9805_CR12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/ndt\/17.suppl_11.39","volume":"17","author":"IC Macdougall","year":"2002","unstructured":"Macdougall IC, Cooper AC (2002) Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines. Nephrol Dial Transplant 17(Suppl 11):39\u201343","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 8","key":"9805_CR13","first-page":"viii17","volume":"18","author":"P Stenvinkel","year":"2003","unstructured":"Stenvinkel P (2003) Anaemia and inflammation: what are the implications for the nephrologists? Nephrol Dial Transplant 18(Suppl 8):viii17\u2013viii22","journal-title":"Nephrol Dial Transplant"},{"key":"9805_CR14","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ajkd.2003.07.016","volume":"42","author":"K Kalantar-Zadeh","year":"2003","unstructured":"Kalantar-Zadeh K, Ikizler TA, Block G et al (2003) Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis 42:864\u2013881","journal-title":"Am J Kidney Dis"},{"key":"9805_CR15","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s11255-006-0077-3","volume":"38","author":"PL Neves","year":"2006","unstructured":"Neves PL, Morgado E, Fa\u00edsca M et al (2006) Nutritional and inflammatory status influence darbepoietin dose in pre-dialysis elderly patients. Int Urol Nephrol 38:811\u2013813","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"9805_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000245041","volume":"29","author":"M Kanbay","year":"2010","unstructured":"Kanbay M, Perazella MA, Kasapoglu B et al (2010) Erythropoiesis stimulatory agent-resistant anemia in dialysis patients: review of causes and management. Blood Purif 29(1):1\u201312","journal-title":"Blood Purif"},{"key":"9805_CR17","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jclinepi.2004.05.002","volume":"57","author":"DJ Cotter","year":"2004","unstructured":"Cotter DJ, Stefanik K, Zhang Y et al (2004) Hematocrit was not validated as a surrogate end point for survival among epoietin-treated hemodialysis patients. J Clin Epidemiol 57:1086\u20131095","journal-title":"J Clin Epidemiol"},{"key":"9805_CR18","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1053\/j.ajkd.2004.08.002","volume":"44","author":"Y Zhang","year":"2004","unstructured":"Zhang Y, Thamer M, Stefanik K et al (2004) Epoietin requirements predict mortality in hemodialysis patients. Am J Kidney Dis 44:866\u2013876","journal-title":"Am J Kidney Dis"},{"key":"9805_CR19","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1681\/ASN.2005090997","volume":"17","author":"DL Regidor","year":"2006","unstructured":"Regidor DL, Kopple JD, Kovesdy CP et al (2006) Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. J Am Soc Nephrol 17:1181\u20131191","journal-title":"J Am Soc Nephrol"},{"key":"9805_CR20","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1038\/ki.2008.523","volume":"74","author":"JM Lopez-Gomez","year":"2008","unstructured":"Lopez-Gomez JM, Porto J, Aljama P (2008) Factors that condition the response to erythropoeitin in patients on hemodialysis and their relation to mortality. Kidney Int 74:S75\u2013S81","journal-title":"Kidney Int"},{"key":"9805_CR21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB et al (1999) A more accurate method to estimate glomerular filtration rate from serum craetinine: a new prediction equation. Ann Intern Med 130:461\u2013470","journal-title":"Ann Intern Med"},{"key":"9805_CR22","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1681\/ASN.V132504","volume":"13","author":"C Hsu","year":"2002","unstructured":"Hsu C, McCulloch CE, Curhan GC (2002) Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol 13:504\u2013510","journal-title":"J Am Soc Nephrol"},{"key":"9805_CR23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0735-1097(02)01938-1","volume":"40","author":"MJ Sarnak","year":"2002","unstructured":"Sarnak MJ, Tighiouart H, Guruprasad M et al (2002) Anemia as a risk factor for cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) study. J Am Coll Cardiol 40:27\u201333","journal-title":"J Am Coll Cardiol"},{"key":"9805_CR24","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000190270","volume":"77","author":"S Kuriyama","year":"1997","unstructured":"Kuriyama S, Tomonari H, Yoshida H et al (1997) Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in non diabetic patients. Nephron 77:176\u2013185","journal-title":"Nephron"},{"key":"9805_CR25","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/dat.20155","volume":"36","author":"PL Neves","year":"2007","unstructured":"Neves PL, Morgado E, Baptista A et al (2007) Anaemia and interleukin-6 are associated with a faster progression to end-stage renal disease. Dial Transplant 36:445\u2013456","journal-title":"Dial Transplant"},{"key":"9805_CR26","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/ndt\/16.2.307","volume":"16","author":"P Jungers","year":"2001","unstructured":"Jungers P, Choukroun G, Oualin Z et al (2001) Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients. Nephrol Dial Transplant 16:307\u2013312","journal-title":"Nephrol Dial Transplant"},{"key":"9805_CR27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.7326\/0003-4819-110-2-108","volume":"110","author":"VS Lim","year":"1989","unstructured":"Lim VS, DeGowin RL, Zavala D et al (1989) Recombinant human erythropoietin treatment in predialysis patients. A double-blind placebo-controlled trial. Ann Intern Med 110:108\u2013114","journal-title":"Ann Intern Med"},{"key":"9805_CR28","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/0272-6386(95)90122-1","volume":"25","author":"DA Revicki","year":"1995","unstructured":"Revicki DA, Brown RE, Feeny DH et al (1995) Health-related quality of life associated with recombinant human erythropoietin therapy in predialysis chronic renal disease patients. Am J Kidney Dis 25:548\u2013554","journal-title":"Am J Kidney Dis"},{"key":"9805_CR29","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1053\/ajkd.2001.21305","volume":"37","author":"J Fink","year":"2001","unstructured":"Fink J, Blahut S, Reddy M et al (2001) Use of erythropoietin before the initiation of dialysis and its impact on mortality. Am J Kidney Dis 37:348\u2013355","journal-title":"Am J Kidney Dis"},{"key":"9805_CR30","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1345\/aph.1K194","volume":"41","author":"FW Maddux","year":"2007","unstructured":"Maddux FW (2007) Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease. Ann Pharmacother 41:1761\u20131769","journal-title":"Ann Pharmacother"},{"issue":"20","key":"9805_CR31","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa062276","volume":"355","author":"TB Drueke","year":"2006","unstructured":"Drueke TB, Locatelli F, Clyne N et al (2006) Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355(20):2071\u20132084","journal-title":"N Engl J Med"},{"key":"9805_CR32","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa065485","volume":"355","author":"AK Singh","year":"2006","unstructured":"Singh AK, Szczech L, Tang KL et al (2006) Correction of anemia with epoietin alfa in chronic kidney disease. N Engl J Med 355:2085\u20132098","journal-title":"N Engl J Med"},{"key":"9805_CR33","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","volume":"361","author":"MA Pfeffer","year":"2009","unstructured":"Pfeffer MA, Burdmann EA, Chen CY et al (2009) A trial of darbepoietin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 361:2019\u20132032","journal-title":"N Engl J Med"},{"key":"9805_CR34","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/ndt\/gfk011","volume":"21","author":"F Locatelli","year":"2006","unstructured":"Locatelli F, Andrulli S, Memoli B et al (2006) Nutritional-inflammation status and resistance to erythropoietin therapy in hemodialysis patients. Nephrol Dial Transplant 21:991\u2013998","journal-title":"Nephrol Dial Transplant"},{"key":"9805_CR35","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0272-6386(97)90339-5","volume":"29","author":"P Barany","year":"1997","unstructured":"Barany P, Divino Filho JC, Bergstrom J (1997) High C-reactive protein is a strong predictor of resistance to erythropoeitin in hemodialysis patients. Am J Kidney Dis 29:565\u2013568","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"9805_CR36","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s11255-007-9226-6","volume":"39","author":"M Wei","year":"2007","unstructured":"Wei M, Bargman JM, Oreopoulus DG (2007) Factors related to erythropoietin hypo-responsiveness in patients on chronic peritoneal dialysis. Int Urol Nephrol 39(3):935\u2013940","journal-title":"Int Urol Nephrol"},{"issue":"suppl 5","key":"9805_CR37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/ndt\/17.suppl_5.32","volume":"17","author":"P Stenvinkel","year":"2002","unstructured":"Stenvinkel P, Barany P (2002) Anaemia, rHuEPO resistance, and cardiovascular disease in end-stage renal failure: links to inflammation and oxidative stress. Nephrol Dial Transplant 17(suppl 5):32\u201337","journal-title":"Nephrol Dial Transplant"},{"key":"9805_CR38","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/ndt\/15.7.953","volume":"15","author":"P Stenvinkel","year":"2000","unstructured":"Stenvinkel P, Heimb\u00fcrger O, Lindholm B et al (2000) Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 15:953\u2013960","journal-title":"Nephrol Dial Transplant"},{"key":"9805_CR39","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/ajcn\/80.2.299","volume":"80","author":"K Kalantar-Zadeh","year":"2004","unstructured":"Kalantar-Zadeh K, Block G, McAllister CJ et al (2004) Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr 80:297\u2013307","journal-title":"Am J Clin Nutr"},{"key":"9805_CR40","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0272-6386(12)80017-5","volume":"16","author":"PM McKevitt","year":"1990","unstructured":"McKevitt PM, Jones JF, Lane DA et al (1990) The elderly on dialysis. Some considerations in compliance. Am J Kidney Dis 16:346\u2013350","journal-title":"Am J Kidney Dis"},{"key":"9805_CR41","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0167-4943(96)86979-2","volume":"22","author":"G Bonanno","year":"1996","unstructured":"Bonanno G, Urso S, Lo Faro F et al (1996) Parathyroid hormone in a population of elderly patients on hemodialysis (preliminary data). Arch Gerontol Geriatr 22:441\u2013445","journal-title":"Arch Gerontol Geriatr"},{"key":"9805_CR42","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000080234","volume":"22","author":"B lorio Di","year":"2004","unstructured":"Di lorio B, Stellato D, De Santo N et al (2004) Association of gender and age with erythropoietin resistance in hemodialysis patients: role of menstrual status. Blood Purif 22:423\u2013427","journal-title":"Blood Purif"},{"key":"9805_CR43","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/ajkd.2001.26842","volume":"38","author":"O Ifudu","year":"2001","unstructured":"Ifudu O, Uribarri J, Rajwani I et al (2001) Gender modulates responsiveness to recombinant erythropoietin. Am J Kidney Dis 38:518\u2013522","journal-title":"Am J Kidney Dis"},{"key":"9805_CR44","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00467-008-0954-3","volume":"24","author":"OF Bamgbola","year":"2009","unstructured":"Bamgbola OF, Kaskel FJ, Coco M (2009) Analyses of age, gender and other risk factors of EPO resistance in pediatric and adult dialysis cohorts. Pediatr Nephrol 24:571\u2013579","journal-title":"Pediatr Nephrol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-010-9805-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-010-9805-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-010-9805-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,31]],"date-time":"2021-10-31T14:31:48Z","timestamp":1635690708000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-010-9805-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,17]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["9805"],"URL":"https:\/\/doi.org\/10.1007\/s11255-010-9805-9","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,17]]}}}